HealthcareServices

De-Identified Health Data Industry Anticipated to Expand at 11.9% CAGR During the Forecast Period

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The De-Identified Health Data Market By 2029?

The de-identified health data market has seen rapid growth in recent years. This market is expected to expand from $8.20 billion in 2024 to $9.20 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.2%. Historically, this expansion has been propelled by the increasing adoption of electronic health records, a heightened awareness of patient data privacy, an upswing in healthcare analytics usage, more extensive research into population health management, the development of health information technology systems, and the increased application of data in clinical trials.

The de-identified health data market size is projected for swift expansion in the coming years. This market is anticipated to reach $14.40 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.8%. Key factors contributing to this anticipated growth involve the increasing application of artificial intelligence within healthcare, a heightened need for real-world evidence in pharmaceutical development, an elevated focus on the secondary utilization of health data, a significant rise in the demand for privacy-enhancing technologies, and the expanding requirement for precision medicine. Noteworthy developments expected during this period encompass the formulation of data privacy protocols, the creation of machine learning pipelines, integration efforts with electronic health records, connections with population health platforms, and advancements in data anonymization methodologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28191&type=smp

Which Industry Drivers Are Expected To Accelerate The De-Identified Health Data Market From 2025 To 2029?

The growing implementation of electronic health records (EHRs) is projected to drive the expansion of the de-identified health data market moving forward. Electronic health records (EHR) denote a digital version of a patient’s complete medical history, encompassing diagnoses, treatments, medications, lab results, and other health data securely stored and shared among authorized healthcare providers. The uptake of electronic health records is increasing due to their capability to enhance patient care and safety by providing accurate, real-time access to extensive medical information. De-identified health data complements electronic health records by facilitating secure data sharing and advanced analytics while safeguarding patient privacy, thereby refining clinical decision-making and healthcare outcomes. As an illustration, in June 2022, the Department of Health and Social Care, a UK-based government department, projected that by March 2025, all NHS trusts will have adopted electronic health records, marking an increase from the 90% adoption rate recorded in December 2023. Consequently, the escalating adoption of electronic health records (EHRs) is fostering the growth of the de-identified health data market.

What Are The Emerging Segments Gaining Attention In The De-Identified Health Data Market?

The de-identified health data market covered in this report is segmented as

1) By Type: Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Hospital And Provider Data, Pharmacogenomic Data

2) By Application: Clinical Research And Trials, Public Health, Precision Medicine, Health Economics And Outcomes Research (HEOR), Population Health Management, Drug Discovery And Development, Healthcare Quality Improvement, Insurance Underwriting And Risk Assessment, Other Applications

3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Insurance Companies Or Healthcare Payers, Research Institutions, Government Agencies, Other End-Users

Subsegments:

1) By Clinical Data: Electronic Health Records, Medical Imaging Data, Laboratory Test Results, Surgical Reports, Pathology Reports, Vital Signs Measurements

2) By Genomic Data: Whole Genome Sequencing Data, Exome Sequencing Data, Single Nucleotide Polymorphism Data, Gene Expression Profiles, Epigenetic Data

3) By Patient Demographics: Age Information, Gender Information, Ethnicity Information, Geographic Location, Socioeconomic Status, Marital Status

4) By Prescription Data: Medication Orders, Dosage Information, Prescription Refill History, Drug Allergies, Pharmacy Dispensation Records

5) By Hospital And Provider Data: Provider Performance Metrics, Care Delivery Outcomes, Billing And Claims Data, Resource Utilization Data

6) By Pharmacogenomic Data: Gene–Drug Interaction Data, Adverse Drug Reaction Data, Personalized Therapy Response Data, Drug Efficacy Variation Data

What Long-Term Trends Will Shape The Future Growth Of The De-Identified Health Data Industry?

Leading companies in the de-identified health data market are concentrating on developing advanced solutions, such as real-world biomarker coverage applications, to facilitate evidence-based healthcare decision-making. These applications utilize de-identified patient data to monitor and evaluate biomarker patterns and effectiveness among diverse populations outside of clinical trials, thereby enabling researchers and healthcare providers to gain insights into treatment responses and disease trends. For instance, in July 2025, Datma Inc., a US-based healthcare technology company, introduced the Federated Biomarker Explorer, a free application designed for pharmaceutical teams to quickly validate real-world biomarker coverage across Datma’s federated network of participating data contributors. This tool delivers aggregated, cohort-level insights into biomarker presence, allowing teams to assess coverage rapidly without needing contracts or IT support. It also enables secure integration of users’ own data for overlap analysis and supports early-stage feasibility assessments with clinical and demographic filtering, which helps verify if datasets contain the necessary patient populations before committing resources.

Who Are The Top Performing Companies In The De-Identified Health Data Market In Recent Years?

Major companies operating in the de-identified health data market are UnitedHealth Group Incorporated, Oracle Corporation, IQVIA Holdings Inc, ICON Public Limited Company, Datavant Inc, Premier Inc., iMerit Technology Services Pvt. Ltd., Tempus Labs Inc., Medidata Solutions Inc., Veradigm Inc., Flatiron Health, Merative LP, Komodo Health Inc., Shaip Inc., Truveta Inc., Evidation Health Inc., TriNetX Inc., Clarify Health Solutions Inc., Akrivia Health Ltd., Gradient Health Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/de-identified-health-data-global-market-report

What Regional Growth Trends Are Shaping The De-Identified Health Data Market Outlook?

North America was the largest region in the de-identified health data market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in de-identified health data report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The De-Identified Health Data Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28191&type=smp

Browse Through More Reports Similar to the Global De-Identified Health Data Market 2025, By The Business Research Company

Artificial Intelligence In The Diagnostic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Artificial Intelligence In Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

Ai In Medical Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795